Biopharma

STAT+: Pharmalittle: We’ve reading about abortion pill maker entering legal fight, a bill to revise IRA, and more

STAT+: Pharmalittle: We’ve reading about abortion pill ...

Feb 26, 2025 0

GenBioPro, the largest manufacturer of abortion pills in the U.S., is wading int...

Roger Perlmutter startup raises $350 million

Roger Perlmutter startup raises $350 million

Feb 26, 2025 0

The biotech news stories you need to read, brought to you by The Readout.

Third recipient of pig kidney heads home from hospital

Third recipient of pig kidney heads home from hospital

Feb 26, 2025 0

Plus more health news stories to stay on top of this morning.

Human medicines European public assessment report (EPAR): Kostaive, zapomeran, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 26, 2025 0

Human medicines European public assessment report (EPAR): Kostaive, zapomeran, S...

Human medicines European public assessment report (EPAR): Micardis, telmisartan, Date of authorisation: 16/12/1998, Revision: 29, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 26, 2025 0

Human medicines European public assessment report (EPAR): Micardis, telmisartan,...

Human medicines European public assessment report (EPAR): Fampridine Accord, fampridine, Date of authorisation: 24/09/2020, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 26, 2025 0

Human medicines European public assessment report (EPAR): Fampridine Accord, fam...

Joint EC/HMA/EMA multi-stakeholder workshop on pharmacogenomics, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 24 September 2024, 09:00 (CEST) to 24 September 2024, 17:00 (CEST)

Joint EC/HMA/EMA multi-stakeholder workshop on pharmaco...

Feb 26, 2025 0

Joint EC/HMA/EMA multi-stakeholder workshop on pharmacogenomics, Online, Europea...

Human medicines European public assessment report (EPAR): MicardisPlus, Date of authorisation: 19/04/2002, Revision: 36, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 26, 2025 0

Human medicines European public assessment report (EPAR): MicardisPlus, Date of ...

Human medicines European public assessment report (EPAR): Herzuma, trastuzumab, Date of authorisation: 09/02/2018, Revision: 24, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 26, 2025 0

Human medicines European public assessment report (EPAR): Herzuma, trastuzumab, ...

Human medicines European public assessment report (EPAR): GeGant, Germanium (68Ge) chloride,Gallium (68Ga) chloride, Status: Application withdrawn

Human medicines European public assessment report (EPAR...

Feb 26, 2025 0

Human medicines European public assessment report (EPAR): GeGant, Germanium (68G...

Human medicines European public assessment report (EPAR): ProQuad, measles, mumps, rubella and varicella vaccine (live), Date of authorisation: 05/04/2006, Revision: 33, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 26, 2025 0

Human medicines European public assessment report (EPAR): ProQuad, measles, mump...

Human medicines European public assessment report (EPAR): Aripiprazole Accord, aripiprazole, Date of authorisation: 15/11/2015, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 26, 2025 0

Human medicines European public assessment report (EPAR): Aripiprazole Accord, a...

Human medicines European public assessment report (EPAR): Sitagliptin SUN, sitagliptin fumarate, Date of authorisation: 09/12/2021, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 26, 2025 0

Human medicines European public assessment report (EPAR): Sitagliptin SUN, sitag...

Human medicines European public assessment report (EPAR): Sunlenca, lenacapavir, Date of authorisation: 17/08/2022, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 26, 2025 0

Human medicines European public assessment report (EPAR): Sunlenca, lenacapavir,...

Human medicines European public assessment report (EPAR): MenQuadfi, meningococcal group A, C, W-135 and Y conjugate vaccine, Date of authorisation: 18/11/2020, Revision: 19, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 26, 2025 0

Human medicines European public assessment report (EPAR): MenQuadfi, meningococc...

Eikon raises $351M in one of the year’s largest biotech venture rounds

Eikon raises $351M in one of the year’s largest biotech...

Feb 26, 2025 0

The funding comes as Eikon, run by former Merck research chief Roger Perlmutter,...

With no buyer for Tryvio, Idorsia claws back $100M from a double-asset deal with Viatris

With no buyer for Tryvio, Idorsia claws back $100M from...

Feb 26, 2025 0

With the latest hopes of licensing its hypertension drug Tryvio falling through,...

ICH Guideline M13A on bioequivalence for immediate-release solid oral dosage forms - Scientific guideline

ICH Guideline M13A on bioequivalence for immediate-rele...

Feb 26, 2025 0

ICH Guideline M13A on bioequivalence for immediate-release solid oral dosage for...

Investigation of bioequivalence - Scientific guideline

Investigation of bioequivalence - Scientific guideline

Feb 26, 2025 0

Investigation of bioequivalence - Scientific guideline

AstraZeneca, eyeing $5B peak sales, reports phase 3 breast cancer win for oral SERD

AstraZeneca, eyeing $5B peak sales, reports phase 3 bre...

Feb 26, 2025 0

AstraZeneca has advanced its push to make camizestrant a blockbuster, reporting ...

Human medicines European public assessment report (EPAR): Bimervax, COVID-19 Vaccine (recombinant, adjuvanted),selvacovatein,damlecovatein, Date of authorisation: 30/03/2023, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 26, 2025 0

Human medicines European public assessment report (EPAR): Bimervax, COVID-19 Vac...

Grail goes 'Grey's': Actor Kate Walsh joins awareness campaign for multi-cancer early detection testing

Grail goes 'Grey's': Actor Kate Walsh joins awareness c...

Feb 26, 2025 0

Blood test maker Grail has recruited ‘Grey’s Anatomy’ star Kate Walsh to join a ...

Human medicines European public assessment report (EPAR): Duaklir Genuair, aclidinium bromide,formoterol, Date of authorisation: 19/11/2014, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 26, 2025 0

Human medicines European public assessment report (EPAR): Duaklir Genuair, aclid...

Human medicines European public assessment report (EPAR): Eklira Genuair, aclidinium bromide, Date of authorisation: 20/07/2012, Revision: 21, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 26, 2025 0

Human medicines European public assessment report (EPAR): Eklira Genuair, aclidi...

8
9
10
11
12

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.